9 news items
Marinus Pharmaceuticals Announces Topline Results from Phase 3 RAISE Trial of IV Ganaxolone in Refractory Status Epilepticus
MRNS
17 Jun 24
of IV anesthesia."
The Company will continue to analyze the full RAISE dataset and plans to engage
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Marinus Pharmaceuticals, Inc. - MRNS
MRNS
15 Jun 24
and certain of its officers and/or directors have engaged in securities
Marinus Pharmaceuticals, Inc. Stockholders with Large Losses Should Contact Robbins LLP About Their Rights in Connection with the MRNS Class Action Lawsuit
MRNS
14 Jun 24
engage in wrongdoing, sign up
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Marinus Pharmaceuticals, Inc. - MRNS
MRNS
13 Jun 24
. The class action concerns whether Marinus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class Action Against Marinus Pharmaceuticals, Inc.
MRNS
11 Jun 24
Pharmaceuticals, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up
23a6znje4dbr9s3icwpzeim4cdu086qgjnvk9lblatjnva bx504kejn
MRNS
7 Jun 24
engage in wrongdoing, sign up
ou3kor4ifig7jkyxgc086yeoqyhu3d848gnjnh
MRNS
6 Jun 24
concerns whether Marinus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices
xvhgo 9m1irqgm5bfvel3thkdygb5b7adbsp9sfk5bys4os03zbet
MRNS
5 Jun 24
corporate executives engage in wrongdoing, sign up
sz09wv186 2ggv6nkhmliudusnwvh5o4zz6wmtuefaymjiuksoiuieqjfjj
MRNS
16 Apr 24
. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly
- Prev
- 1
- Next